OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Incidence of Severe COVID-19 Illness Following Vaccination and Booster With BNT162b2, mRNA-1273, and Ad26.COV2.S Vaccines
J. Daniel Kelly, Samuel Leonard, Katherine J. Hoggatt, et al.
JAMA (2022) Vol. 328, Iss. 14, pp. 1427-1427
Open Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

SARS-CoV-2 viral clearance and evolution varies by type and severity of immunodeficiency
Yijia Li, Manish C. Choudhary, James Regan, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 731
Open Access | Times Cited: 48

Comparing frequency of booster vaccination to prevent severe COVID-19 by risk group in the United States
Hailey J. Park, Gregg Gonsalves, Sophia T. Tan, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 14

Individual costs and societal benefits of interventions during the COVID-19 pandemic
Arne Traulsen, Simon A. Levin, Chadi M. Saad-Roy
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 24
Open Access | Times Cited: 21

Comparative Effectiveness of mRNA-1273 and BNT162b2 COVID-19 Vaccines Among Older Adults: Systematic Literature Review and Meta-Analysis Using the GRADE Framework
S Kavikondala, Katrin Haeussler, Xuan Wang, et al.
Infectious Diseases and Therapy (2024) Vol. 13, Iss. 4, pp. 779-811
Open Access | Times Cited: 10

SARS-CoV-2 post-acute sequelae in previously hospitalised patients: systematic literature review and meta-analysis
J. Daniel Kelly, Tristan Curteis, Aaditya Rawal, et al.
European Respiratory Review (2023) Vol. 32, Iss. 169, pp. 220254-220254
Open Access | Times Cited: 20

SARS-CoV-2 infection following booster vaccination: Illness and symptom profile in a prospective, observational community-based case-control study
Michela Antonelli, Rose Penfold, Liane S. Canas, et al.
Journal of Infection (2023) Vol. 87, Iss. 6, pp. 506-515
Open Access | Times Cited: 17

A comprehensive perspective on the interaction between gut microbiota and COVID-19 vaccines
Ming Hong, Tin Lan, Qiuxia Li, et al.
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 12

The Efficacy of SARS-CoV-2 Vaccination in the Elderly: A Systemic Review and Meta-analysis
Xiu Hong Yang, Wen Jing Bao, Hua Zhang, et al.
Journal of General Internal Medicine (2023)
Open Access | Times Cited: 11

Editorial: COVID-19 booster vaccination: increasing immunity against life-threatening infection
Ritthideach Yorsaeng, Kamolthip Atsawawaranunt, Abanoub Riad
Frontiers in Public Health (2024) Vol. 11
Open Access | Times Cited: 2

Pneumonia Prevalence Upon Chest Radiography According to Vaccination Status Among Patients Under 50 Years of Age With Coronavirus Disease 2019
Yong Shik Kwon, Sun Hyo Park, Hyun Jung Kim, et al.
Journal of Korean Medical Science (2024) Vol. 39, Iss. 6
Open Access | Times Cited: 2

COVID-19 outcome trends by vaccination status in Canada, December 2020–January 2022
Demy Dam, Sharifa Merali, Michelle Chen, et al.
Canada Communicable Disease Report (2024) Vol. 50, Iss. 1/2, pp. 40-48
Open Access | Times Cited: 2

Declining Levels of Neutralizing Antibodies to SARS-CoV-2 Omicron Variants Are Enhanced by Hybrid Immunity and Original/Omicron Bivalent Vaccination
Sharon Walmsley, Majid Nabipoor, Freda Qi, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 564-564
Open Access | Times Cited: 2

Comparative mRNA booster effectiveness against death or hospitalization with COVID-19 pneumonia across at-risk US Veteran populations
J. Daniel Kelly, Samuel Leonard, W. John Boscardin, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 6

SARS-CoV-2 Viral Clearance and Evolution Varies by Extent of Immunodeficiency
Yijia Li, Manish C. Choudhary, James Regan, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 6

NEURO-COVAX: An Italian Population-Based Study of Neurological Complications after COVID-19 Vaccinations
Maria Salsone, Carlo Signorelli, Alessandro Oldani, et al.
Vaccines (2023) Vol. 11, Iss. 10, pp. 1621-1621
Open Access | Times Cited: 6

Understanding COVID-19 Vaccine Uptake and Hesitancy among People with HIV in Freetown, Sierra Leone: A Cross-Sectional Study
Peterlyn E. Cummings, Sulaiman Lakoh, Sahr A. Yendewa, et al.
Vaccines (2023) Vol. 11, Iss. 11, pp. 1685-1685
Open Access | Times Cited: 6

Association Between Coronavirus Disease 2019 and Acute Complicated Diverticulitis
Christian Karime, Paul Travers, A. El Ouni, et al.
Cureus (2023)
Open Access | Times Cited: 5

Factors Associated with Pneumonia in Patients Hospitalized with COVID-19 and the Role of Vaccination
Antonella Zizza, Raffaella Sedile, Francesco Bagordo, et al.
Vaccines (2023) Vol. 11, Iss. 8, pp. 1342-1342
Open Access | Times Cited: 5

Broadly potent anti-SARS-CoV-2 antibody shares 93% of epitope with ACE2 and provides full protection in monkeys
Craig Fenwick, Priscilla Turelli, Yoan Duhoo, et al.
Journal of Infection (2023) Vol. 87, Iss. 6, pp. 524-537
Open Access | Times Cited: 5

Page 1 - Next Page

Scroll to top